These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17667477)

  • 1. Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics.
    Frazier JA; McCLELLAN J; Findling RL; Vitiello B; Anderson R; Zablotsky B; Williams E; McNAMARA NK; Jackson JA; Ritz L; Hlastala SA; Pierson L; Varley JA; Puglia M; Maloney AE; Ambler D; Hunt-Harrison T; Hamer RM; Noyes N; Lieberman JA; Sikich L
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):979-988. PubMed ID: 17667477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.
    Frazier JA; Giuliano AJ; Johnson JL; Yakutis L; Youngstrom EA; Breiger D; Sikich L; Findling RL; McClellan J; Hamer RM; Vitiello B; Lieberman JA; Hooper SR
    J Am Acad Child Adolesc Psychiatry; 2012 May; 51(5):496-505. PubMed ID: 22525956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition in early-onset schizophrenia and schizoaffective disorders.
    Hooper SR; Giuliano AJ; Youngstrom EA; Breiger D; Sikich L; Frazier JA; Findling RL; McClellan J; Hamer RM; Vitiello B; Lieberman JA
    J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):52-60. PubMed ID: 20215926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Gabriel D; Jakubovski E; Taylor JH; Artukoglu BB; Bloch MH
    Psychiatry Res; 2017 Sep; 255():248-255. PubMed ID: 28595147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.
    Kao YC; Liu YP
    BMC Psychiatry; 2010 Aug; 10():63. PubMed ID: 20718964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of older patients with bipolar disorder and schizophrenia/schizoaffective disorder.
    Gupta S; Steinmeyer CH; Lockwood K; Lentz B; Schultz K
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):627-33. PubMed ID: 17586787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.
    McCLELLAN J; Sikich L; Findling RL; Frazier JA; Vitiello B; Hlastala SA; Williams E; Ambler D; Hunt-Harrison T; Maloney AE; Ritz L; Anderson R; Hamer RM; Lieberman JA
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):969-978. PubMed ID: 17667476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
    Norman RM; Malla AK; Manchanda R; Townsend L
    Acta Psychiatr Scand; 2005 Jul; 112(1):30-9. PubMed ID: 15952943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
    Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
    J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
    J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premorbid adjustment in schizophrenia and schizoaffective disorder.
    Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
    Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.
    Smith MJ; Barch DM; Csernansky JG
    Schizophr Res; 2009 Jan; 107(1):69-75. PubMed ID: 18786811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning and age at onset in non-affective psychotic disorder.
    van der Werf M; Köhler S; Verkaaik M; Verhey F; van Os J;
    Acta Psychiatr Scand; 2012 Oct; 126(4):274-81. PubMed ID: 22582732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.